LLY News and Press, Eli Lilly and Company From 04/17/24

2024-04-17 18:51:53 ET For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side). Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical ...

2024-04-17 12:02:34 ET More on Eli Lilly Wall Street Lunch: Lilly In Limelight Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Eli Lilly obesity therapy succeeds in late-sta...

2024-04-17 11:27:00 ET Summary Eli Lilly's tirzepatide reached main goals in two Phase 3 trials for patients with obesity and obstructive sleep apnea. Abbott posts Q1 results beat, Travelers earnings hurt by elevated catastrophe losses. Mortgage servicing within housing-financ...

2024-04-17 10:30:28 ET More on Inspire Medical Systems Inspire Medical Systems: A Potential Example Of Market Mispricing Inspire Medical Systems: Strong Q4 Results But Growth Might Be Slowing Inspire Medical: A Good Night Sleep Baird puts Inspire on top idea ...

2024-04-17 09:22:00 ET U.S. stock index futures on Wednesday were higher, pointing to a rebound from the previous session. Wall Street's rate cut expectations took another hit after Federal Reserve chair Jerome Powell made some hawkish comments on Tuesday. Here are some stocks to w...

2024-04-17 07:04:07 ET More on Eli Lilly Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Eli Lilly: Diabetes And Weight Management Treatments Are The Winning Tickets GLP-1s ...

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity PR Newswire Tirzepatide achieved a mean apnea-hypopnea index reduction of up to 63% (about 30 fewer events per hour), meeting all primary and key second...

2024-04-17 03:10:00 ET Summary March CPI data was not what the bulls wanted to see, just as concerns about household spending emerge. This week, we profile a pair of domestic consumer companies, one from the Staples sector and one from Discretionary, with off-trend Q1 reporting da...

2024-04-16 16:59:57 ET More on Precision BioSciences Precision BioSciences stock falls after pricing $40M securities offering Precision BioSciences announces proposed public offering of common stock and warrants Seeking Alpha’s Quant Rating on Precision BioSci...

2024-04-16 16:36:58 ET Summary Inadequate pension savings and ever-increasing longevity is threatening investors' well-being in retirement. Planning for retirement is a life-long process, the earlier you start the better. This allows you to benefit from the full power of compoundi...